{
    "2019-04-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Ophthotech Gets Rights to Gene Therapy for BEST Disease",
                "features": {
                    "keywords": [
                        "Ophthotech",
                        "Gene Therapy",
                        "BEST Disease"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal",
                "features": {
                    "keywords": [
                        "AZN",
                        "MRK",
                        "GSK",
                        "Regulatory Approvals",
                        "Sandoz"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Rizmoic",
                        "Sandoz",
                        "Alcon",
                        "Spin Off"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}